Cyphaira Corp. CYPA
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 1,149.25% | 1,226.67% | 1,413.99% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1,149.25% | 1,226.67% | 1,413.99% | -- | -- |
| Cost of Revenue | 431.14% | 608.19% | 1,550.35% | -- | -- |
| Gross Profit | 708.84% | 1,063.11% | 1,020.00% | -- | -- |
| SG&A Expenses | 28.99% | 58.58% | 105.09% | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 81.55% | 112.67% | 166.53% | -- | -- |
| Operating Income | 11.60% | -26.44% | -90.72% | -- | -- |
| Income Before Tax | 4.39% | -27.68% | -78.40% | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 4.39% | -27.68% | -78.40% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 68.41% | 195.44% | 1,190.65% | -- | -- |
| Net Income | 23.78% | 0.80% | -29.18% | -- | -- |
| EBIT | 11.60% | -26.44% | -90.72% | -- | -- |
| EBITDA | 15.78% | -27.34% | -105.31% | -- | -- |
| EPS Basic | -31.91% | -22.86% | -39.19% | -- | -- |
| Normalized Basic EPS | 17.74% | 16.10% | -7.87% | -- | -- |
| EPS Diluted | -10.71% | -1.18% | -6.74% | -- | -- |
| Normalized Diluted EPS | 17.74% | 16.10% | -7.87% | -- | -- |
| Average Basic Shares Outstanding | -19.94% | -1.08% | 57.69% | -- | -- |
| Average Diluted Shares Outstanding | -19.94% | -1.08% | 57.69% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |